Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Do small RNAs have potential in disease diagnosis and treatment?47
Advances and required improvements in methods to diagnosing Clostridioides difficile infections in the healthcare setting44
Association betweenCDH1methylation and esophageal cancer risk: a meta-analysis and bioinformatics study44
Survival Outcome and Clinicopathologicl analysis of Homeobox gene cluster-embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis42
Predictive biomarkers and personalized pharmacotherapy40
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects40
RT-LAMP in SARS-CoV-2 detection: point to improve primer designing and decrease molecular diagnosis pitfalls37
Whole genome amplicon sequencing and phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from lineage B.1.36.27 isolated in Hong Kong31
Development and validation of a ligand–receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer26
Advances in rapid diagnostic tests for myocardial infarction patients25
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis23
SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma23
Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis23
Point-of-care testing for viral-associated pulmonary aspergillosis22
Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast DMD variant heterogeneity22
From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers22
SOWAHB polymorphisms affect thyroid cancer risk in the Chinese Han population22
The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis22
Recent advances in the diagnosis monkeypox: implications for public health22
Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa22
An overview of point-of-care testing for infections in critically ill patients22
Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples22
0.069382905960083